Evidence map›Paper›PMID 32600276›Full record

ArticleBMC pediatrics2020

Genotype-phenotype correlation in two Polish neonates with alveolar capillary dysplasia.

Zuzanna Kozłowska, Zuzanna Owsiańska, Joanna P Wroblewska, Apolonia Kałużna, Andrzej Marszałek, Yogen Singh, Bartłomiej Mroziński, Qian Liu, Justyna A Karolak, Paweł Stankiewicz and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Zuzanna KozłowskaDepartment of Neonatology, Neonatal Biophysical Monitoring and Cardiopulmonary Therapies Research Unit, Poznan University of Medical Sciences, Poznan, Poland. zuzanna.kozlowska@yahoo.pl.ORCID 0000-0002-7750-048X
Zuzanna OwsiańskaDepartment of Neonatology, Neonatal Biophysical Monitoring and Cardiopulmonary Therapies Research Unit, Poznan University of Medical Sciences, Poznan, Poland.
Joanna P WroblewskaDepartment of Pathology, Poznan University of Medical Sciences and Greater Poland Cancer Center, Poznan, Poland.
Apolonia KałużnaDepartment of Pathology, Poznan University of Medical Sciences and Greater Poland Cancer Center, Poznan, Poland.
Andrzej MarszałekDepartment of Pathology, Poznan University of Medical Sciences and Greater Poland Cancer Center, Poznan, Poland.
Yogen SinghDepartment of Neonatology and Paediatric Cardiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Bartłomiej MrozińskiDepartment of Pediatric Cardiology and Nephrology, Poznan University of Medical Sciences, Poznan, Poland.
Qian LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Justyna A KarolakChair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Poznan, Poland.
Paweł StankiewiczDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Gail DeutschDepartment of Pathology, Seattle Children's Hospital, Seattle, USA.
Marta Szymankiewicz-BręborowiczDepartment of Neonatology, Neonatal Biophysical Monitoring and Cardiopulmonary Therapies Research Unit, Poznan University of Medical Sciences, Poznan, Poland.
Tomasz SzczapaDepartment of Neonatology, Neonatal Biophysical Monitoring and Cardiopulmonary Therapies Research Unit, Poznan University of Medical Sciences, Poznan, Poland.
Poznan University of Medical Sciences · PLBaylor College of Medicine · USCambridge University Hospitals NHS Foundation Trust · GBSeattle Children's Hospital · US

Funding

Epigenomic dysfunction at 16q24.1 vascular defects and perinatal consequencesR01HL137203 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI STANKIEWICZ, PAWEL · 2017 to 2020
$2.0M
NHLBI NIH HHS R01 HL137203
6 · The paper itself

Abstract

backgroundAlveolar capillary dysplasia (ACD) is a rare cause of severe pulmonary hypertension and respiratory failure in neonates. The onset of ACD is usually preceded by a short asymptomatic period. The condition is refractory to all available therapies as it irreversibly affects development of the capillary bed in the lungs. The diagnosis of ACD is based on histopathological evaluation of lung biopsy or autopsy tissue or genetic testing of FOXF1 on chromosome 16q24.1. Here, we describe the first two Polish patients with ACD confirmed by histopathological and genetic examination. CASE PRESENTATION: The patients were term neonates with high Apgar scores in the first minutes of life. They both were diagnosed prenatally with heart defects. Additionally, the first patient presented with omphalocele. The neonate slightly deteriorated around 12

conclusionsBoth patients presented with a distinct course of ACD, extra-pulmonary manifestations and response to medications. Surgery and ceasing of prostaglandin E1 infusion should be considered as potential causes of this variability. We further highlight the necessity of thorough genetic testing and histopathological examination and propose immunostaining for CD31 and CD34 to facilitate the diagnostic process for better management of infants with ACD.

Indexed as

Forkhead Transcription FactorsComparative Genomic HybridizationGenetic Association StudiesHumansInfantInfant, NewbornPersistent Fetal Circulation SyndromePolandPulmonary AlveoliForkhead Transcription FactorsFOXF1 protein, humanAlveolar capillary dysplasiaFOXF1 mutationNeonatePulmonary hypertensionRespiratory failure

Identifiers

PMID32600276
PMCPMC7322906
OpenAlexW3038099753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.